Elixinol Wellness Ltd (EXL)

Not featured in screeners

Not featured in screeners

Top insiders

Company data & Insiders

Download results Settings

Pauline Gately

1 sale — total 20,097 AUD

Sale 21 Sep 2023

Value A$4,455,817.49 | Price 415.01 | Shares 86,784

Helen Wiseman

1 purchase — total 65,000 AUD

Planned buy 31 May 2023

Value A$1,280,889.44 | Price 140.17 | Shares 22,156

David Fenlon

1 purchase — total 45,000 AUD

Buy 31 May 2023

Value A$45,000.00 | Price 0.02 | Shares 2,500,000

Ronald Dufficy

1 purchase — total 161,018 AUD

Planned buy 31 May 2023

Value A$161,018.15 | Price 0.02 | Shares 8,945,453

Paul Benhaim

1 sale — total 23,474 AUD

Sale 30 Dec 2021

Value A$23,473.70 | Price 0.07 | Shares 313,791

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2023-10-18	2023-09-21	S Sale	Pauline Gately Director	86,784 415.01 A$4,455,817	86,784	415.01	A$4,455,817
2023-05-31	2023-05-31	PP Planned purchase	Helen Wiseman Director	22,156 140.17 A$1,280,889	22,156	140.17	A$1,280,889
2023-05-31	2023-05-31	B Purchase	David Fenlon Director	71,703 16.28 A$4,411,316	71,703	16.28	A$4,411,316
2023-05-31	2023-05-31	PP Planned purchase	Ronald Dufficy Director	8,945,453 0.02 A$161,018	8,945,453	0.02	A$161,018
2021-12-30	2021-12-30	S Sale	Paul Benhaim Director	313,791 0.07 A$23,474	313,791	0.07	A$23,474

More insider trading research around Elixinol Wellness Ltd